Nontuberculous mycobacterial pulmonary disease

Current Opinion in Pulmonary Medicine

Volumn 4, Issue 3, 1998, Pages 148-153

  Olivier, Kenneth N ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BACTERIAL PNEUMONIA; CLASSIFICATION; CYSTIC FIBROSIS; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; LUNG DISEASE; MIDDLE AGED; MYCOBACTERIOSIS; MYCOBACTERIUM; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK FACTOR;

ADULT; AGED; CYSTIC FIBROSIS; GUIDELINES; HUMANS; INCIDENCE; LUNG DISEASES; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; PNEUMONIA, BACTERIAL; PROGNOSIS; RISK FACTORS;

EID: 0032060003     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wallace RJ Jr, O'Brien R, Glassroth J, Raleigh J, Dutt A: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990, 142:940-953.
2. Wallace RJ Jr, Glassroth J, Griffith DE, Olivier KN, Cook JL, Gordin F: American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997, 156:S1-S25. An updated treatise on NTM disease. Highlights listed at the beginning of the statement include: 1) revised diagnostic criteria for NTM pulmonary disease that discourage "colonization" and are more liberal toward diagnosing disease; 2) laboratory advances, including the use of DNA probes and the role of susceptibility testing; 3) prophylaxis regimens for MAC in the HIV-positive patient; 4) improved treatment regimens.
3. Christianson LC, Dewlett HJ: Pulmonary disease in adults associated with unclassified mycobacteria. Am J Med 1960, 29:980-991.
4. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE: An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969, 99:1-132.
5. Good RC, Snider DE: Isolation of nontuberculous mycobacteria in the United States. J Infect Dis 1980, 146:829-833.
6. O'Brien RJ, Geiter LJ, Snider DE: The epidemiology of nontuberculous mycobacterial diseases in the United States: results of a national survey. Am Rev Respir Dis 1987, 135:1007-1014.
7. rd American Society for Microbiology General Meeting. Abstract U-9:170.
8. Cox JN, Brenner ER, Bryan CS: Changing patterns of mycobacterial disease at a teaching community hospital. Infect Control Hosp Epidemiol 1994, 15:513-515.
9. Contreras MA, Cheung OT, Sanders DE, Goldstein RS: Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 1988, 137:149-152.
10. Tanaka E, Amitani R, Nimi A, Suzuki K, Murayama T, Kuze F: Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997, 155:2041-2046. The low sensitivity of expectorated sputum in yielding a diagnosis of MAC infection in patients presenting with nodular or bronchiectatic disease is emphasized by culturing MAC from bronchial washings in patients with biopsy-confirmed disease with negative or minimal growth sputum examinations.
11. Tanaka E, Lee WJ, Yuba Y, Hashimoto T, Suzuki K, Amitani R, Kuze F: Computed tomography findings of pulmonary infections caused by Mycobacterium avium complex in patients without predisposing conditions. Am J Respir Crit Care Med 1994, 149:108A.
12. Hirano K, Kadono K, Saitoh T, Watanabe S, Hasegawa S: Multi-drug chemotherapy including clarithromycin: short-term response of early diagnosed Mycobacterium avium complex pulmonary disease in patients without preexistent pulmonary disease [abstract]. Am J Respir Crit Care Med 1997, 155:A335. Very preliminary study suggesting a role for early intervention in patients with nodular or bronchiectactic disease due to MAC.
13. Scully R, Mark E, McNeely W: Case records of the Massachusetts General Hospital. N Engl J Med 1996, 334:521-526.
14. Kubo K, Yamazaki Y, Takamizawa A, Tsukadaira M, Masubuchi T, Yamamoto H, Kaneki T, Hachiya T, Fujimoto K, Matsuzawa Y, Sekiguchi M, Honda T: Pulmonary function tests in patients with pulmonary M. avium complex infection. Am J Respir Crit Care Med 1997, 155:A335.
15. Embil J, Warren P, Yakrus M, Stark R, Corne S, Forrest D, Hershfield E: Pulmonary illness associated with exposure to Mycobacterium avium complex in hot tub water: hypersensitivity pneumonitis or infection? Chest 1997, 111:813-816.
16. Fergie JE, Milligan TW, Henderson BM, Stafford WW: Intrathoracic Mycobacterium avium complex infection in immunocompetent children: case report and review. Clin Infect Dis 1997, 24:250-253. An increasingly reported, presentation of MAC disease primarily occurring in children under age 5 presenting with wheezing recalcitrant to bronchodilators.
17. Shih JY, Wang HC, Chiang IP, Yang PC, Luh KT: Endobronchial lesions in a non-AIDS patient with disseminated Mycobacterium avium-intracellulare infection. Eur Respir J 1997, 10:497-499.
18. Jiva TM, Jacoby HM, Weymouth LA, Kaminski DA, Portmore AC: Mycobacterium xenopi: Innocent bystander of emerging pathogen? Clin Infect Dis 1997, 24:226-232.
19. Fishman JE, Schwartz DS, Sais GJ: Mycobacterium kansasii pulmonary Infection in patients with AIDS: spectrum of chest radiographic findings. Radiology 1997, 204:171-175.
20. Olivier KN, Yankaskas JR, Knowles MR: Nontuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect 1996, 11:272-284. Comprehensive review of available information regarding NTM disease in this patient population.
21. Whittier S, Olivier K, Gilligan P, Knowles M, Della-Latta P: Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. J Clin Microbiol 1997, 35:2706-2708.
22. Oermann CM, Starke JR, Seilheimer DK: Pulmonary disease caused by Mycobacterium kansasii in a patient with cystic fibrosis. Pediatr Infect Dis J 1997, 16:257-259.
23. Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT, Onyi GO, Steingrube VA, Mazurek GH: Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med 1994, 149:1335-1341.
24. Griffith DE, Brown BA, Girard WM, Murphy DT, Wallace RJ Jr: Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clin Infect Dis 1996, 23:983-989.
25. Wallace RJ Jr, Brown BA, Griffith DE, Girard WM, Murphy DT: Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients. Am J Respir Crit Care Med 1996, 153:1766-1772.
26. Griffith DE, Brown BA, Murphy D, Girard WM, Wallace RJ Jr: Initial results of three times weekly azithromycin for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 1997, 155:A334.
27. Peloquin CA, Nitta AT, Burman WJ, Brudney KF, Miranda-Massari JR, McGuinness ME, Berning SE, Gerena GT: Low antituberculosis drug concentrations in patients with AIDS. Ann Pharmacother 1996, 30:919-925.
28. Larsson LO, Gilljam M, Berning SE, Peloquin CA: Is monitoring of drug therapy in patients with cystic fibrosis and mycobacterial disease necessary? [abstract]. Am J Respir Crit Care Med 1997, 155:A642.